Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:1468-1474, doi:10.1016/S0735-1097(03)00243-2
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cosín-Sales, J.
Right arrow Articles by Kaski, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosín-Sales, J.
Right arrow Articles by Kaski, J. C.

CLINICAL STUDY

C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms

Juan Cosín-Sales, MD*, Carmine Pizzi, MD*, Sue Brown, BSc, RGN* and Juan Carlos Kaski, MD, DSc, FACC, FESC, FRCP*,*

* Coronary Artery Disease Research Unit, Department of Cardiological Sciences, St. George’s Hospital Medical School, London, United Kingdom

Manuscript received September 11, 2002; revised manuscript received November 12, 2002, accepted December 12, 2002.

* Reprint requests and correspondence: Dr. Juan Carlos Kaski, Coronary Artery Disease Research Unit, Department of Cardiological Sciences, St. George’s Hospital Medical School, Cranmer Terrance, London SW17 0RE, United Kingdom.
jkaski{at}sghms.ac.uk

OBJECTIVES: We sought to investigate the relationship among C-reactive protein (hs-CRP), clinical characteristics, exercise stress test responses, and ST-segment changes during daily life in patients with typical chest pain and normal coronary angiograms (CPNCA).

BACKGROUND: Patients with CPNCA have coronary microvascular endothelial dysfunction and myocardial ischemia. Elevated hs-CRP levels have been related to atherogenesis and endothelial dysfunction. The relationship between hs-CRP and disease activity has not been previously investigated in CPNCA patients.

METHODS: We studied 137 consecutive CPNCA patients (mean age, 57 ± 9; 33 men). All completed standardized angina questionnaires, underwent exercise stress testing, 24-h ambulatory electrocardiogram (ECG) monitoring (Holter), and hs-CRP measurements at study entry.

RESULTS: C-reactive protein levels (mg/l) were higher in patients with frequent (2.9 ± 3.3) and prolonged (3.9 ± 4.1) chest pain episodes, and in those with ST-segment depression on exercise testing (2.6 ± 2.8) and Holter monitoring (3.4 ± 3.1) compared with patients with occasional (1.3 ± 1.2; p = 0.002) or shorter chest pain (1.5 ± 1.3; p < 0.001) episodes, negative exercise stress testing (1.1 ± 1.1; p < 0.001), and no ST-segment shifts on Holter monitoring (0.9 ± 0.7; p < 0.001). Moreover, we found a correlation between hs-CRP concentration and number of ischemic episodes during Holter monitoring (r = 0.65; p < 0.001) and with the magnitude of ST-segment depression on exercise testing (r = –0.43; p < 0.001). The hs-CRP was the only independent variable (multivariate logistic regression) capable of predicting positive findings on Holter monitoring (odds ratio [OR], 3.8; confidence interval [CI], 2.3 to 6.2) and exercise testing (OR, 1.7; CI, 1.2 to 2.2).

CONCLUSIONS: The hs-CRP correlates with symptoms and ECG markers of myocardial ischemia in CPNCA patients. Whether hs-CRP is related to the pathogenesis of angina in these patients deserves further investigation.

Abbreviations and Acronyms
  CI = confidence interval
  CPNCA = chest pain and normal coronary arteriogram
  CRP = C-reactive protein
  ECG = electrocardiogram
  ET-1 = endothelin-1
  hs-CRP = high-sensitivity C-reactive protein
  ICAM-1 = intercellular cell adhesion molecule-1
  OR = odds ratio
  VCAM-1 = vascular cell adhesion molecule-1




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. J. Pennell
Perfusion abnormality, normal coronaries, and chest pain.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 473 - 475.
[Full Text] [PDF]


Home page
HeartHome page
P.-H. Huang, Y.-H. Chen, Y.-L. Chen, T.-C. Wu, J.-W. Chen, and S.-J. Lin
Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X
Heart, September 1, 2007; 93(9): 1064 - 1070.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G A Lanza
Cardiac syndrome X: a critical overview and future perspectives
Heart, February 1, 2007; 93(2): 159 - 166.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
R. Arroyo-Espliguero and J. C. Kaski
Microvascular dysfunction in cardiac syndrome X: the role of inflammation.
Can. Med. Assoc. J., June 20, 2006; 174(13): 1833 - 1833.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al.
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381.
[Full Text] [PDF]


Home page
HeartHome page
J C Kaski
Cardiac syndrome X in women: the role of oestrogen deficiency
Heart, May 1, 2006; 92(suppl_3): iii5 - iii9.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. M. Okin, M. J. Roman, L. G. Best, E. T. Lee, J. M. Galloway, B. V. Howard, and R. B. Devereux
C-Reactive Protein and Electrocardiographic ST-Segment Depression Additively Predict Mortality: The Strong Heart Study
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1787 - 1793.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Tomai
C reactive protein and microvascular function
Heart, July 1, 2004; 90(7): 727 - 728.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F. Crea and G. A Lanza
Angina pectoris and normal coronary arteries: cardiac syndrome X
Heart, April 1, 2004; 90(4): 457 - 463.
[Full Text] [PDF]


Home page
CirculationHome page
J. C. Kaski
Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X)
Circulation, February 10, 2004; 109(5): 568 - 572.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y. W. Lew, and S. Tsimikas
Highlights of the year in JACC 2003
J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2156 - 2166.
[Full Text] [PDF]


Home page
Eur Heart JHome page
R. Arroyo-Espliguero, N. Mollichelli, P. Avanzas, E. Zouridakis, V. R Newey, D. K Nassiri, and J. C. Kaski
Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X
Eur. Heart J., November 2, 2003; 24(22): 2006 - 2011.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement